Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01496053
Recruitment Status : Completed
First Posted : December 21, 2011
Last Update Posted : October 8, 2020
Sponsor:
Collaborator:
ImmunoPharma AS
Information provided by (Responsible Party):
Egil Johnson, Oslo University Hospital